Staar Surgical Company (STAA)

$29.99 +0.13 (0.44%)
Market Cap 1.49B
Revenue (ttm) 239.44M
Net Income (ttm) -80.45M
EPS (ttm) N/A
PE Ratio 123.87
Forward PE 219.15
Profit Margin -33.60%
Debt to Equity Ratio 0.00
Volume 566,500
Avg Vol 1,066,896
Day's Range N/A - N/A
Shares Out 49.79M
Stochastic %K 31%
Beta 1.23
Analysts Sell
Price Target $30.22

Company Profile

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, and sells phakic implantable lenses for the eye and accessory delivery systems to deliver the lenses into the eye. The company offers implantable collamer lens product family (ICLs) comprising EVO ICL, EVO+ ICL, EVO Visian ICL, and EVO Viva ICL for use in refractive surgery for the treatment of visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It serves health care providers, includin...

Industry: Medical Instruments & Supplies
Sector: Healthcare
Phone: 626 303 7902
Fax: 626 359 8402
Address:
25510 Commercentre Drive, Lake Forest, United States
stoks9
stoks9 May. 29 at 9:26 PM
$STAA fd up stock but I like it
1 · Reply
stocksmit
stocksmit May. 28 at 7:46 PM
$STAA another odd dip on the day. I’m just buying a few every day 35 was not enough pre good China future outlook, so to me, 35 is a minimum here.
0 · Reply
Laynester
Laynester May. 22 at 11:38 AM
$STAA TURNAROUND play. ON it! Not sure why Health care is a big deal really like the recent results tho. Long term indicators look great. All in on the L'ins (LENS) market. Set a stop good to all investors. 100%--->🦬
0 · Reply
stocksmit
stocksmit May. 20 at 3:43 PM
$STAA lol. Well, 70,000 share wall put up at 34 bucks so probably not gonna run over that I’d imagine
0 · Reply
TradeSun
TradeSun May. 20 at 2:42 PM
$ALT $STAA GC incoming... $XBI
0 · Reply
CaptainAmrica
CaptainAmrica May. 20 at 2:31 PM
$STAA ..Sold for 160% in two months.
1 · Reply
DNoise
DNoise May. 19 at 11:27 PM
$STAA I like the stock, slowly cumulating a share position
0 · Reply
DNoise
DNoise May. 15 at 2:29 AM
$STAA tomorrow it either goes back to pre earnings prices or we see a nice cup & handle on a great company takeover. I like the second option better
0 · Reply
StockBraker
StockBraker May. 14 at 8:37 PM
$STAA
0 · Reply
Estimize
Estimize May. 14 at 8:02 PM
Wall St is expecting 0.21 EPS for $STAA Q2 [Reporting 08/12 AMC] http://www.estimize.com/intro/staa?chart=historical&metric_name=eps&utm_co
0 · Reply
Latest News on STAA
STAAR Surgical Company Transcript: Status update

May 27, 2026, 2:30 PM EDT - 9 days ago

STAAR Surgical Company Transcript: Status update

STAAR Surgical Company Transcript: Stifel 2026 Virtual Ophthalmology Forum

May 26, 2026, 4:30 PM EDT - 10 days ago

STAAR Surgical Company Transcript: Stifel 2026 Virtual Ophthalmology Forum

STAAR Surgical Announces Participation in Upcoming Investor Conferences

May 21, 2026, 4:01 PM EDT - 15 days ago

STAAR Surgical Announces Participation in Upcoming Investor Conferences

Staar Surgical upgraded to Outperform from Neutral at Wedbush

2026-05-14T13:33:17.000Z - 22 days ago

Staar Surgical upgraded to Outperform from Neutral at Wedbush

Staar Surgical price target raised to $32 from $27 at Canaccord

2026-05-14T13:12:37.000Z - 22 days ago

Staar Surgical price target raised to $32 from $27 at Canaccord

Staar Surgical price target raised to $27 from $22 at Mizuho

2026-05-14T12:38:32.000Z - 22 days ago

Staar Surgical price target raised to $27 from $22 at Mizuho

Wedbush upgrades Staar Surgical to Outperform on China rebound

2026-05-14T12:03:20.000Z - 22 days ago

Wedbush upgrades Staar Surgical to Outperform on China rebound

Staar Surgical price target raised to $31 from $18 at Stifel

2026-05-14T11:32:55.000Z - 22 days ago

Staar Surgical price target raised to $31 from $18 at Stifel

Staar Surgical price target raised to $33 from $16 at Piper Sandler

2026-05-14T11:11:23.000Z - 22 days ago

Staar Surgical price target raised to $33 from $16 at Piper Sandler

STAAR Surgical Company Earnings Call Transcript: Q1 2026

May 13, 2026, 5:30 PM EDT - 23 days ago

STAAR Surgical Company Earnings Call Transcript: Q1 2026

STAAR Surgical Company Earnings release: Q1 2026

May 13, 2026, 5:30 PM EDT - 23 days ago

STAAR Surgical Company Earnings release: Q1 2026

STAAR Surgical Company Quarterly report: Q1 2026

May 13, 2026, 5:30 PM EDT - 23 days ago

STAAR Surgical Company Quarterly report: Q1 2026

STAAR Surgical to Host First Quarter 2026 Earnings Results Call and Webcast on May 13, 2026

May 4, 2026, 4:01 PM EDT - 4 weeks ago

STAAR Surgical to Host First Quarter 2026 Earnings Results Call and Webcast on May 13, 2026

STAAR Surgical Company Proxy statement: Proxy filing

May 4, 2026, 8:00 AM EDT - 4 weeks ago

STAAR Surgical Company Proxy statement: Proxy filing

STAAR Surgical Company Proxy statement: Proxy filing

May 4, 2026, 8:00 AM EDT - 4 weeks ago

STAAR Surgical Company Proxy statement: Proxy filing

Staar Surgical price target raised to $26 from $21 at Wedbush

2026-04-09T13:44:01.000Z - 2 months ago

Staar Surgical price target raised to $26 from $21 at Wedbush

Staar Surgical upgraded to Buy from Hold at Canaccord

2026-04-09T08:55:11.000Z - 2 months ago

Staar Surgical upgraded to Buy from Hold at Canaccord

Staar Surgical up 18% at $24.64 after above-consensus Q1 pre-announcement

2026-04-08T20:05:14.000Z - 2 months ago

Staar Surgical up 18% at $24.64 after above-consensus Q1 pre-announcement

STAAR Surgical Announces Preliminary Net Sales for First Quarter 2026

Apr 8, 2026, 4:01 PM EDT - 2 months ago

STAAR Surgical Announces Preliminary Net Sales for First Quarter 2026

Staar Surgical price target lowered to $22 from $28 at Mizuho

2026-03-05T12:44:40.000Z - 3 months ago

Staar Surgical price target lowered to $22 from $28 at Mizuho

Staar Surgical price target lowered to $18 from $19 at Stifel

2026-03-04T13:41:00.000Z - 3 months ago

Staar Surgical price target lowered to $18 from $19 at Stifel

STAAR Surgical Company Earnings Call Transcript: Q4 2025

Mar 3, 2026, 5:30 PM EST - 3 months ago

STAAR Surgical Company Earnings Call Transcript: Q4 2025

STAAR Surgical Company Earnings release: Q4 2025

Mar 3, 2026, 5:30 PM EST - 3 months ago

STAAR Surgical Company Earnings release: Q4 2025

STAAR Surgical Company Shareholder letter: Q4 2025

Mar 3, 2026, 5:30 PM EST - 3 months ago

STAAR Surgical Company Shareholder letter: Q4 2025

STAAR Surgical Company Annual report: Q4 2025

Mar 3, 2026, 5:30 PM EST - 3 months ago

STAAR Surgical Company Annual report: Q4 2025

STAAR Surgical Issues Shareholder Letter

Mar 3, 2026, 4:02 PM EST - 3 months ago

STAAR Surgical Issues Shareholder Letter

STAAR Surgical Reports Fourth Quarter and Fiscal Year 2025 Results

Mar 3, 2026, 4:01 PM EST - 3 months ago

STAAR Surgical Reports Fourth Quarter and Fiscal Year 2025 Results

STAAR Surgical Surpasses 4 Million ICLs Sold Globally, Reflecting Ongoing Shift Away from Laser-Based Vision Correction

Feb 25, 2026, 4:01 PM EST - 3 months ago

STAAR Surgical Surpasses 4 Million ICLs Sold Globally, Reflecting Ongoing Shift Away from Laser-Based Vision Correction

STAAR Surgical to Host Fourth Quarter and Fiscal Year 2025 Earnings Conference Call and Webcast on March 3, 2026

Feb 23, 2026, 4:01 PM EST - 3 months ago

STAAR Surgical to Host Fourth Quarter and Fiscal Year 2025 Earnings Conference Call and Webcast on March 3, 2026

FDA Expands U.S. Age Indication for EVO ICL as Long-Term Safety Data Reinforces Market Shift Away From Laser Vision Correction

Feb 17, 2026, 4:01 PM EST - 3 months ago

FDA Expands U.S. Age Indication for EVO ICL as Long-Term Safety Data Reinforces Market Shift Away From Laser Vision Correction

STAAR Surgical Appoints Warren Foust and Deborah Andrews Interim Co-CEOs

Feb 2, 2026, 7:00 AM EST - 4 months ago

STAAR Surgical Appoints Warren Foust and Deborah Andrews Interim Co-CEOs

STAAR Surgical and Broadwood Partners Enter Into Cooperation Agreement

Jan 15, 2026, 8:30 AM EST - 5 months ago

STAAR Surgical and Broadwood Partners Enter Into Cooperation Agreement

Alcon Terminates Agreement to Acquire STAAR Surgical

Jan 6, 2026, 8:00 PM EST - 5 months ago

Alcon Terminates Agreement to Acquire STAAR Surgical

ALC

Broadwood Partners Comments on STAAR Surgical Shareholders' Rejection of the Company's Proposed Sale to Alcon

Jan 6, 2026, 9:52 AM EST - 5 months ago

Broadwood Partners Comments on STAAR Surgical Shareholders' Rejection of the Company's Proposed Sale to Alcon

ALC

Staar Surgical to reject Alcon takeover bid after failing to win shareholder backing

Jan 6, 2026, 9:46 AM EST - 5 months ago

Staar Surgical to reject Alcon takeover bid after failing to win shareholder backing

ALC

STAAR Surgical Announces Preliminary Results of Special Meeting of Stockholders

Jan 6, 2026, 8:47 AM EST - 5 months ago

STAAR Surgical Announces Preliminary Results of Special Meeting of Stockholders

Broadwood Partners Denounces STAAR Surgical's Fourth Delay of the Shareholder Vote on the Company's Proposed Sale to Alcon

Dec 19, 2025, 12:59 PM EST - 6 months ago

Broadwood Partners Denounces STAAR Surgical's Fourth Delay of the Shareholder Vote on the Company's Proposed Sale to Alcon

ALC

Alcon Exercises Right to Require STAAR Surgical to Adjourn its Special Meeting of Stockholders

Dec 19, 2025, 11:45 AM EST - 6 months ago

Alcon Exercises Right to Require STAAR Surgical to Adjourn its Special Meeting of Stockholders

ALC

STAAR Surgical Company Proxy statement: Proxy Filing

Dec 19, 2025, 7:00 AM EST - 6 months ago

STAAR Surgical Company Proxy statement: Proxy Filing

Defender Capital Reiterates Intention to Vote AGAINST STAAR Surgical's Proposed Sale to Alcon Inc.

Dec 17, 2025, 4:53 PM EST - 6 months ago

Defender Capital Reiterates Intention to Vote AGAINST STAAR Surgical's Proposed Sale to Alcon Inc.

ALC

Broadwood Partners Issues Open Letter to STAAR Surgical Board Pledging Cooperation and Support When Vote on Alcon Transaction Fails

Dec 17, 2025, 1:17 PM EST - 6 months ago

Broadwood Partners Issues Open Letter to STAAR Surgical Board Pledging Cooperation and Support When Vote on Alcon Transaction Fails

ALC

STAAR Stockholders Have a Choice: Vote FOR Alcon's Certain, Premium $30.75 Per Share Cash Offer or Bear the Downside Risk that Broadwood Has No Credible Plan to Create Stockholder Value

Dec 17, 2025, 10:55 AM EST - 6 months ago

STAAR Stockholders Have a Choice: Vote FOR Alcon's Certain, Premium $30.75 Per Share Cash Offer or Bear the Downside Risk that Broadwood Has No Credible Plan to Create Stockholder Value

ALC

STAAR Surgical Company Proxy statement: Proxy Filing

Dec 17, 2025, 7:00 AM EST - 6 months ago

STAAR Surgical Company Proxy statement: Proxy Filing

Yunqi Capital Comments on Proxy Advisors' Updated Recommendations, Urges Shareholders to Continue to Back the Company's Standalone Trajectory

Dec 16, 2025, 1:32 PM EST - 6 months ago

Yunqi Capital Comments on Proxy Advisors' Updated Recommendations, Urges Shareholders to Continue to Back the Company's Standalone Trajectory

Independent Industry Analysts Recognize Value Provided to STAAR Stockholders by Amended Alcon Merger Agreement and Merits of Alcon Transaction

Dec 16, 2025, 9:12 AM EST - 6 months ago

Independent Industry Analysts Recognize Value Provided to STAAR Stockholders by Amended Alcon Merger Agreement and Merits of Alcon Transaction

ALC

Broadwood Partners Comments on ISS Report on Proposed Sale of STAAR Surgical to Alcon

Dec 16, 2025, 7:00 AM EST - 6 months ago

Broadwood Partners Comments on ISS Report on Proposed Sale of STAAR Surgical to Alcon

ALC

STAAR Surgical Company Proxy statement: Proxy Filing

Dec 16, 2025, 7:00 AM EST - 6 months ago

STAAR Surgical Company Proxy statement: Proxy Filing

STAAR Surgical Company Proxy statement: Proxy Filing

Dec 16, 2025, 7:00 AM EST - 6 months ago

STAAR Surgical Company Proxy statement: Proxy Filing

Leading Independent Proxy Advisory Firm ISS Recommends STAAR Stockholders Vote “FOR” Alcon Merger

Dec 15, 2025, 6:35 PM EST - 6 months ago

Leading Independent Proxy Advisory Firm ISS Recommends STAAR Stockholders Vote “FOR” Alcon Merger

Broadwood Partners: Leading Proxy Advisory Firm Glass Lewis Reaffirms Recommendation “AGAINST” STAAR Surgical Sale to Alcon

Dec 12, 2025, 8:40 AM EST - 6 months ago

Broadwood Partners: Leading Proxy Advisory Firm Glass Lewis Reaffirms Recommendation “AGAINST” STAAR Surgical Sale to Alcon

ALC

STAAR Surgical Sets the Record Straight Regarding its Robust Go-Shop Process

Dec 11, 2025, 9:47 AM EST - 6 months ago

STAAR Surgical Sets the Record Straight Regarding its Robust Go-Shop Process

ALC

Broadwood Partners Comments on STAAR Surgical Board Dissent on the Revised Sale to Alcon

Dec 11, 2025, 7:00 AM EST - 6 months ago

Broadwood Partners Comments on STAAR Surgical Board Dissent on the Revised Sale to Alcon

ALC

STAAR Surgical Company Proxy statement: Proxy Filing

Dec 11, 2025, 7:00 AM EST - 6 months ago

STAAR Surgical Company Proxy statement: Proxy Filing

Yunqi Capital Comments on STAAR Surgical's Go-Shop Process and Alcon's Revised Offer

Dec 10, 2025, 7:05 AM EST - 6 months ago

Yunqi Capital Comments on STAAR Surgical's Go-Shop Process and Alcon's Revised Offer

ALC

STAAR Surgical Company Proxy statement: Proxy Filing

Dec 10, 2025, 7:00 AM EST - 6 months ago

STAAR Surgical Company Proxy statement: Proxy Filing

STAAR Surgical Company Proxy statement: Proxy Filing

Dec 10, 2025, 7:00 AM EST - 6 months ago

STAAR Surgical Company Proxy statement: Proxy Filing

Broadwood Partners Responds to Alcon's Increase to Proposed Acquisition Price of STAAR Surgical

Dec 9, 2025, 12:39 PM EST - 6 months ago

Broadwood Partners Responds to Alcon's Increase to Proposed Acquisition Price of STAAR Surgical

ALC

Alcon Announces Amended Merger Agreement with STAAR Surgical

Dec 9, 2025, 8:30 AM EST - 6 months ago

Alcon Announces Amended Merger Agreement with STAAR Surgical

ALC

STAAR Surgical Company Proxy statement: Proxy Filing

Dec 9, 2025, 7:00 AM EST - 6 months ago

STAAR Surgical Company Proxy statement: Proxy Filing

Broadwood Partners Reiterates Opposition to STAAR Surgical's Sale to Alcon Following Conclusion of Performative Go-Shop Process

Dec 8, 2025, 1:28 PM EST - 6 months ago

Broadwood Partners Reiterates Opposition to STAAR Surgical's Sale to Alcon Following Conclusion of Performative Go-Shop Process

ALC

Broadwood Partners: Proxy Advisory Firm Egan-Jones Reaffirms Its Recommendation STAAR Surgical Shareholders Vote “AGAINST” Sale to Alcon

Dec 8, 2025, 8:16 AM EST - 6 months ago

Broadwood Partners: Proxy Advisory Firm Egan-Jones Reaffirms Its Recommendation STAAR Surgical Shareholders Vote “AGAINST” Sale to Alcon

ALC

STAAR Surgical Announces Expiration of Go-Shop Period

Dec 8, 2025, 8:00 AM EST - 6 months ago

STAAR Surgical Announces Expiration of Go-Shop Period

ALC

STAAR Surgical Company Proxy statement: Proxy Filing

Dec 8, 2025, 7:00 AM EST - 6 months ago

STAAR Surgical Company Proxy statement: Proxy Filing

Broadwood Partners Working to Call Special Meeting of STAAR Surgical Shareholders to Remove Three Directors

Dec 2, 2025, 4:14 PM EST - 6 months ago

Broadwood Partners Working to Call Special Meeting of STAAR Surgical Shareholders to Remove Three Directors

STAAR Surgical Company Proxy statement: Proxy Filing

Nov 17, 2025, 7:00 AM EST - 7 months ago

STAAR Surgical Company Proxy statement: Proxy Filing

Broadwood Partners Calls for the Appointment of New Directors at STAAR Surgical to Oversee Go-Shop Process

Nov 10, 2025, 8:00 AM EST - 7 months ago

Broadwood Partners Calls for the Appointment of New Directors at STAAR Surgical to Oversee Go-Shop Process

ALC

STAAR Surgical Announces Amendments to Alcon Merger Agreement

Nov 7, 2025, 10:10 AM EST - 7 months ago

STAAR Surgical Announces Amendments to Alcon Merger Agreement

ALC

STAAR Surgical Company Proxy statement: Proxy Filing

Nov 7, 2025, 7:00 AM EST - 7 months ago

STAAR Surgical Company Proxy statement: Proxy Filing

Yunqi Capital Applauds STAAR Surgical's Strong Third Quarter Results and Reiterates That the Proposed Sale to Alcon Should Be Terminated

Nov 6, 2025, 6:21 AM EST - 7 months ago

Yunqi Capital Applauds STAAR Surgical's Strong Third Quarter Results and Reiterates That the Proposed Sale to Alcon Should Be Terminated

STAAR Surgical Reports Third Quarter 2025 Results

Nov 5, 2025, 4:01 PM EST - 7 months ago

STAAR Surgical Reports Third Quarter 2025 Results

STAAR Surgical Company Earnings release: Q3 2025

Nov 5, 2025, 4:00 PM EST - 7 months ago

STAAR Surgical Company Earnings release: Q3 2025

Broadwood Partners Condemns Alcon's Fallacious Attacks on STAAR Surgical and Its Prospects

Nov 4, 2025, 11:52 AM EST - 7 months ago

Broadwood Partners Condemns Alcon's Fallacious Attacks on STAAR Surgical and Its Prospects

ALC

Yunqi Capital Issues Letter to STAAR Surgical Board Calling for Termination of the Proposed Merger with Alcon

Oct 31, 2025, 12:00 PM EDT - 7 months ago

Yunqi Capital Issues Letter to STAAR Surgical Board Calling for Termination of the Proposed Merger with Alcon

ALC

STAAR Surgical Company Proxy statement: Proxy Filing

Oct 30, 2025, 8:00 AM EDT - 7 months ago

STAAR Surgical Company Proxy statement: Proxy Filing

STAAR Surgical Company Proxy statement: Proxy Filing

Oct 28, 2025, 8:00 AM EDT - 7 months ago

STAAR Surgical Company Proxy statement: Proxy Filing

STAAR Surgical Sets New Record Date and Postpones STAAR Special Meeting of Stockholders in Light of Ongoing Discussions with Alcon

Oct 27, 2025, 8:00 AM EDT - 7 months ago

STAAR Surgical Sets New Record Date and Postpones STAAR Special Meeting of Stockholders in Light of Ongoing Discussions with Alcon

ALC

STAAR Surgical Company Proxy statement: Proxy Filing

Oct 27, 2025, 8:00 AM EDT - 7 months ago

STAAR Surgical Company Proxy statement: Proxy Filing

Yunqi Capital Issues Letter to STAAR Surgical Board Opposing Adjournment of the Special Meeting and Calling for the Company to Move Beyond the Proposed Merger with Alcon

Oct 24, 2025, 6:03 PM EDT - 8 months ago

Yunqi Capital Issues Letter to STAAR Surgical Board Opposing Adjournment of the Special Meeting and Calling for the Company to Move Beyond the Proposed Merger with Alcon

ALC

Broadwood Partners Condemns Decision by STAAR Surgical and Alcon to Delay Final Vote on Proposed Transaction

Oct 24, 2025, 8:00 AM EDT - 8 months ago

Broadwood Partners Condemns Decision by STAAR Surgical and Alcon to Delay Final Vote on Proposed Transaction

ALC

Alcon and STAAR Surgical Announce Adjournment of STAAR Special Meeting of Stockholders

Oct 23, 2025, 12:09 PM EDT - 8 months ago

Alcon and STAAR Surgical Announce Adjournment of STAAR Special Meeting of Stockholders

ALC

STAAR Surgical Company Proxy statement: Proxy Filing

Oct 23, 2025, 8:00 AM EDT - 8 months ago

STAAR Surgical Company Proxy statement: Proxy Filing

Staar Surgical's top investor calls shareholder meeting to remove directors

Oct 22, 2025, 7:44 AM EDT - 8 months ago

Staar Surgical's top investor calls shareholder meeting to remove directors

Broadwood Partners Intends to Call Special Meeting to Remove Several STAAR Surgical Directors

Oct 22, 2025, 6:17 AM EDT - 8 months ago

Broadwood Partners Intends to Call Special Meeting to Remove Several STAAR Surgical Directors

Yunqi Capital Issues Letter to STAAR Surgical's Board Calling for Timely Convening of the Special Meeting to Vote on the Alcon Transaction

Oct 20, 2025, 5:32 PM EDT - 8 months ago

Yunqi Capital Issues Letter to STAAR Surgical's Board Calling for Timely Convening of the Special Meeting to Vote on the Alcon Transaction

ALC

Broadwood Partners Highlights Growing Opposition to STAAR Surgical's Proposed Sale to Alcon

Oct 20, 2025, 8:42 AM EDT - 8 months ago

Broadwood Partners Highlights Growing Opposition to STAAR Surgical's Proposed Sale to Alcon

ALC

STAAR Surgical Company Proxy statement: Proxy Filing

Oct 20, 2025, 8:00 AM EDT - 8 months ago

STAAR Surgical Company Proxy statement: Proxy Filing

STAAR Surgical Announces Preliminary Net Sales Results for Third Quarter 2025

Oct 20, 2025, 7:30 AM EDT - 8 months ago

STAAR Surgical Announces Preliminary Net Sales Results for Third Quarter 2025

Broadwood Partners Issues Letter to STAAR Surgical's Board Urging it to Allow Timely Shareholder Vote on Alcon Sale

Oct 17, 2025, 8:00 AM EDT - 8 months ago

Broadwood Partners Issues Letter to STAAR Surgical's Board Urging it to Allow Timely Shareholder Vote on Alcon Sale

ALC

STAAR Surgical Affirms that No Acquisition Proposals Have Been Received From Any Party Other Than Alcon

Oct 16, 2025, 4:15 PM EDT - 8 months ago

STAAR Surgical Affirms that No Acquisition Proposals Have Been Received From Any Party Other Than Alcon

stoks9
stoks9 May. 29 at 9:26 PM
$STAA fd up stock but I like it
1 · Reply
stocksmit
stocksmit May. 28 at 7:46 PM
$STAA another odd dip on the day. I’m just buying a few every day 35 was not enough pre good China future outlook, so to me, 35 is a minimum here.
0 · Reply
Laynester
Laynester May. 22 at 11:38 AM
$STAA TURNAROUND play. ON it! Not sure why Health care is a big deal really like the recent results tho. Long term indicators look great. All in on the L'ins (LENS) market. Set a stop good to all investors. 100%--->🦬
0 · Reply
stocksmit
stocksmit May. 20 at 3:43 PM
$STAA lol. Well, 70,000 share wall put up at 34 bucks so probably not gonna run over that I’d imagine
0 · Reply
TradeSun
TradeSun May. 20 at 2:42 PM
$ALT $STAA GC incoming... $XBI
0 · Reply
CaptainAmrica
CaptainAmrica May. 20 at 2:31 PM
$STAA ..Sold for 160% in two months.
1 · Reply
DNoise
DNoise May. 19 at 11:27 PM
$STAA I like the stock, slowly cumulating a share position
0 · Reply
DNoise
DNoise May. 15 at 2:29 AM
$STAA tomorrow it either goes back to pre earnings prices or we see a nice cup & handle on a great company takeover. I like the second option better
0 · Reply
StockBraker
StockBraker May. 14 at 8:37 PM
$STAA
0 · Reply
Estimize
Estimize May. 14 at 8:02 PM
Wall St is expecting 0.21 EPS for $STAA Q2 [Reporting 08/12 AMC] http://www.estimize.com/intro/staa?chart=historical&metric_name=eps&utm_co
0 · Reply
StocktwitsNews
StocktwitsNews May. 14 at 4:31 PM
STAA Stock On Track For Its Fourth Straight Session Of Gains – This Analyst Would Rather Be Early Than Late On Staar’s Growth Story $STAA https://stocktwits.com/news/equity/markets/staa-stock-on-track-for-its-fourth-straight-session-of-gains-earnings-analysts-upgrade-stock/cZX1wjjReSd
0 · Reply
V2IcedPriate
V2IcedPriate May. 14 at 3:34 PM
$STAA
0 · Reply
ripster47
ripster47 May. 14 at 3:28 PM
$STAA | Wedbush Upgrades STAAR Surgical to Outperform, PT $40 China recovery and strong market position drive long-term growth potential 🔹 Follow @tenet_research for more analyst insights on Other Tickers!
0 · Reply
V2IcedPriate
V2IcedPriate May. 14 at 3:00 PM
$STAA
0 · Reply
ccdemuth
ccdemuth May. 14 at 2:49 PM
$STAA https://stwsactionthisday.substack.com/p/steal
0 · Reply
DNoise
DNoise May. 14 at 2:13 PM
$STAA
0 · Reply
StockBraker
StockBraker May. 14 at 1:59 PM
$STAA Strange reversal. I guess if we hit $30 or less I'm going to buy back the shares sold this morning at $36.
0 · Reply
JFDI
JFDI May. 14 at 1:35 PM
$STAA back from the dead
0 · Reply
GetVector
GetVector May. 14 at 12:51 PM
Vector Intelligence (VI) is an algorithm designed to predict potential outsized intraday moves. VI will select up to 4 stocks per day. Today's VI stocks: $CSIQ, $DOCS, $GO, $STAA.
0 · Reply
JohnPDaly
JohnPDaly May. 14 at 12:45 PM
$LCTX Rich Uncle Neal looking good on $STAA .
1 · Reply
OpenOutcrier
OpenOutcrier May. 14 at 12:34 PM
$STAA (+17.3% pre) STAAR Surgical (NASDAQ:STAA) Beats Expectations in Strong Q1 CY2026, Stock Jumps https://ooc.bz/l/102274
0 · Reply
V2IcedPriate
V2IcedPriate May. 14 at 11:51 AM
$STAA curling up
0 · Reply